Challenging the "Extensive Development Process" of the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders

By Kean, Brian | Ethical Human Psychology and Psychiatry, April 1, 2013 | Go to article overview
Save to active project

Challenging the "Extensive Development Process" of the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders

Kean, Brian, Ethical Human Psychology and Psychiatry

It is evident, over the past 30 years, that there has been widespread promotion of the concept of a biological basis for psychiatric disorders and direct promotion on the belief by medical experts in media, texts, and public meetings. In developed countries, and in particular die United States, this has resulted in epidemic comparable increases in the percentage of the population that are diagnosed as having a psychiatric disorder.

The associated increases in drug-based treatments have resulted in financial benefits to pharmaceutical companies and medical experts. This relationship raises questions con- cerning the construction of knowledge, particularly in light of the claims promoting a proven biological/neurological basis for many psychiatric disorders that, at diis point, has not been clearly established in research (Healy, 2012; Whitaker, 2010).

The claims made in the biopsychiatric discourse are supported dirough reference to experts' opinions, scientific research studies, and reports in refereed journals. Linked to the research studies and journal articles are medical experts, many in esteemed positions in universities, whose power over the discourse is impenetrable even to practicing physicians, nurses, other health workers, education systems, teachers, parents, and the individuals diagnosed with a mental health disorder.

Understanding the context of the hegemonic medical model of psychiatry is critical given the rapid increases in the number of individuals diagnosed with psychiatric disor- ders. What is considered normal in a society varies over time and die definition of devi- ance can and does change in accordance with the values of a society. The increased use of psychiatric diagnoses raises questions concerning the forces in society that have led to die acceptance of, and increasing promotion of drug regimes for an ever-increasing number of psychiatric disorders, evident in each new edition of die American Psychiatric Association's (APA; 2011) Diagnostic and Statistical Manual of Mental Disorders (DSM). With die imminent release of the DSM-5 in 2013, diis issue of the journal has a focus on questioning aspects of the hegemonic psychiatric discourse.

Individual and community expectations of psychiatric medical intervention are that treatments will produce positive outcomes and result in improvements in die functioning of individuals diagnosed widi a mental health problem. However, negative consequences from pharmaceutical and biopsychiatric treatments are not new or uncommon phenomena. Iatrogenic outcomes resulting from adverse drug reactions have been well documented in medicine (illustrated by die devastating consequences of dialidomide) and in biopsychiatry (illustrated by the development of tardive dyskinesia in a significant percentage of patients as a result of long-term treatment with neuroleptic drugs; Lader, 1993).

This issue of the journal concludes with an In Memoriam to Thomas Szasz. Szasz was one of the first significant critics of biopsychiatry. Szasz's initial text The My[h of Mental Illness, first published in 1961, critiqued the biopsychiatric construct of mental illness and outlined the potentially flawed constructs of biopsychiatry. Szasz's critical commentary was underpinned by libertarian views. He was damning of the role of psychiatry because of its coercive nature, reflected by involuntary treatment programs. Szasz's analysis extended beyond the problems of coercion associated with psychiatric intervention, and condemned the very construct of mental illness and associated treatments (Szasz, 1976).

In Pharmacracy, published in 2001, Szasz refined his analysis, defining "pharmacracy" as a totalitarian regime of social control that uses drug therapy as the main regulating mecha- nism (Szasz, 2001). The agents of the regime are the health care professionals, principally psychiatrists, whose certifying role classifies, what Szasz perceived as, socially undesirable, unacceptable, or criminal behavior as diseases and results in die use of psychotropic drugs and other biopsychiatric interventions for treatment and solution.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Cite this article

Cited article

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Challenging the "Extensive Development Process" of the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders


Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?